Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold

Thu, 16th Sep 2021 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

EXANE BNP RAISES STANDARD CHARTERED TO 'NEUTRAL' (UNDERPERFORM)

----------

DEUTSCHE BANK CUTS SHELL PRICE TARGET TO 1,871 (1,937) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BP PRICE TARGET TO 320 (313) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS ANGLO AMERICAN PRICE TARGET TO 3,600 (3,700) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS ANTOFAGASTA PRICE TARGET TO 1,310 (1,320) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS RIO TINTO PRICE TARGET TO 6,000 (6,600) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BHP GROUP PRICE TARGET TO 2,200 (2,400) PENCE - 'HOLD'

----------

DEUTSCHE BANK RAISES GLENCORE PRICE TARGET TO 440 (420) PENCE - 'BUY'

----------

RBC RAISES GLENCORE PRICE TARGET TO 400 (360) PENCE - 'OUTPERFORM'

----------

GOLDMAN RAISES GLENCORE PRICE TARGET TO 430 (390) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS UNILEVER TO 'HOLD' (BUY) - PRICE TARGET 4,600 (4,800) PENCE

----------

JPMORGAN RAISES JD SPORTS FASHION TARGET TO 1,350 (1,300) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

CREDIT SUISSE RAISES REDROW PRICE TARGET TO 745 (640) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES REDROW PRICE TARGET TO 800 (673) PENCE - 'BUY'

----------

BARCLAYS RAISES REDROW PRICE TARGET TO 820 (810) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES REDROW PRICE TARGET TO 850 (790) PENCE - 'OVERWEIGHT'

----------

BARCLAYS RAISES DRAX GROUP PRICE TARGET TO 960 (550) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES VESUVIUS PRICE TARGET TO 760 (685) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BRITVIC TO 'HOLD' ('BUY') - TARGET 950 PENCE

----------

BERENBERG RAISES TRUSTPILOT PRICE TARGET TO 440 (430) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

CITIGROUP RAISES SOUTH32 PRICE TARGET TO 200 (185) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 195 (165) PENCE - 'HOLD'

----------

BERENBERG CUTS PAN AFRICAN RESOURCES PRICE TARGET TO 25 (29) PENCE - 'BUY'

----------

RBC CUTS CLINIGEN PRICE TARGET TO 860 (935) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES KEYWORDS STUDIOS TARGET TO 3,550 (3,200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES KEYWORDS STUDIOS PRICE TARGET TO 3,700 (3,450) PENCE - 'BUY'

----------

BARCLAYS CUTS FEVERTREE DRINKS PRICE TARGET TO 2,400 (2,500) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES FEVERTREE DRINKS PRICE TARGET TO 2,200 (2,100) PENCE - 'HOLD'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Sep 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
2 Sep 2021 14:28

Clinigen signs UK distribution deal for Paion hospital drugs

Clinigen signs UK distribution deal for Paion hospital drugs

Read more
1 Sep 2021 14:07

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

EXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director

Read more
1 Sep 2021 09:12

Allen out, Schnee in as Cliningen board chairman

(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.

Read more
25 Aug 2021 20:39

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

EXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway

Read more
25 Aug 2021 07:34

Clinigen CFO Nick Keher steps down

(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".

Read more
5 Aug 2021 10:45

Clinigen inks partnership agreement with Eyevance Pharmaceuticals

(Sharecast News) - Pharmaceutical firm Clinigen said on Thursday that it has inked an exclusive partnership agreement with Eyevance Pharmaceuticals, a wholly-owned subsidiary of Santen Pharmaceutical.

Read more
5 Aug 2021 10:42

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Clinigen partners with Eyevance to supply antifungal drug Natacyn

Read more
3 Aug 2021 15:29

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

EXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork

Read more
21 Jul 2021 14:44

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

IN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq

Read more
14 Jul 2021 13:23

Wednesday broker round-up

(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.

Read more
13 Jul 2021 10:43

Clinigen expects annual revenue rise in transitional year

Clinigen expects annual revenue rise in transitional year

Read more
13 Jul 2021 09:36

Clinigen ends year in line with expectations

(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.

Read more
11 Jul 2021 18:55

Sunday share tips: Clinigen, UK companies

(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.